Drug Discovery Today: Technologies

1

Biomarkers for pharmacogenetic and pharmacogenomic studies: special issues in analytical performance

Elizabeth Mansfield, Zivana Tezak, Sousan Altaie, Kathleen Simon, Steven Gutman

Journal:

Year:

2007

Language:

english

File:

PDF, 80 KB

english, 2007

3

Biomarkers for pharmacogenetic and pharmacogenomic studies: Locking down analytical performance

Elizabeth Mansfield, Zivana Tezak, Sousan Altaie, Kathleen Simon, Steven Gutman

Journal:

Drug Discovery Today: Technologies

Year:

2007

Language:

english

File:

PDF, 84 KB

english, 2007

4

Questions and answers about the Pilot Process for Biomarker Qualification at the FDA

Federico M. Goodsaid, Felix W. Frueh

Journal:

Drug Discovery Today: Technologies

Year:

2007

Language:

english

File:

PDF, 74 KB

english, 2007

5

Display considerations for quantitative radiology

Aldo Badano

Journal:

Drug Discovery Today: Technologies

Year:

2007

Language:

english

File:

PDF, 1.16 MB

english, 2007

6

FDA's proactive role in the development of an artificial pancreas for the treatment of diabetes mellitus

Arleen Pinkos, Guillermo Arreaza-Rubin, William J. Heetderks, Ilan Irony, Hylton V. Joffe, Bruce Schneider, Charles L. Zimliki

Journal:

Drug Discovery Today: Technologies

Year:

2007

Language:

english

File:

PDF, 99 KB

english, 2007

7

An integrated bioinformatics infrastructure essential for advancing pharmacogenomics and personalized medicine in the context of the FDA's Critical Path Initiative

Weida Tong, Stephen C. Harris, Hong Fang, Leming Shi, Roger Perkins, Federico Goodsaid, Felix W. Frueh

Journal:

Drug Discovery Today: Technologies

Year:

2007

Language:

english

File:

PDF, 1.20 MB

english, 2007

8

Metabolomic biomarkers: their role in the critical path

Laura K. Schnackenberg, Richard D. Beger

Journal:

Drug Discovery Today: Technologies

Year:

2007

Language:

english

File:

PDF, 93 KB

english, 2007

9

FDA's Critical Path Initiative

Janet Woodcock

Journal:

Drug Discovery Today: Technologies

Year:

2007

Language:

english

File:

PDF, 69 KB

english, 2007

Volume 4; Issue 1

Contents

Biomarkers for pharmacogenetic and pharmacogenomic studies: special issues in analytical performance

Biomarkers for pharmacogenetic and pharmacogenomic studies: Locking down analytical performance

Questions and answers about the Pilot Process for Biomarker Qualification at the FDA

Display considerations for quantitative radiology

FDA's proactive role in the development of an artificial pancreas for the treatment of diabetes mellitus

An integrated bioinformatics infrastructure essential for advancing pharmacogenomics and personalized medicine in the context of the FDA's Critical Path Initiative

Metabolomic biomarkers: their role in the critical path

FDA's Critical Path Initiative